| Nov 21 |
Corbus Pharmaceuticals to Present at the 7th Annual Evercore HealthCONx Conference
|
| Nov 12 |
Corbus Pharmaceuticals to Present at the Jefferies London Healthcare Conference
|
| Nov 11 |
Corbus Pharmaceuticals' Sell-Off: Speculative Entry Price In Oncology And Obesity Therapies
|
| Nov 9 |
We're Not Very Worried About Corbus Pharmaceuticals Holdings' (NASDAQ:CRBP) Cash Burn Rate
|
| Nov 7 |
Corbus Pharmaceuticals: Q3 Earnings Snapshot
|
| Nov 7 |
Corbus Pharmaceuticals Reports 3rd Quarter 2024 Financial Results and Provides a Corporate Update
|
| Nov 4 |
Viking Therapeutics Tumbles As Obesity Competition Sabotages Its Novo Nordisk Beat
|
| Nov 4 |
Corbus Pharmaceuticals Presents New CRB-913 Pre-Clinical Data At Obesity Week 2024
|
| Oct 29 |
Corbus Pharmaceuticals to Present at the Guggenheim Securities Healthcare Innovation Conference
|
| Oct 16 |
Corbus Announces Enrollment Completion of Dose Escalation Stage of Phase 1 Clinical Trial of Its Next Generation Nectin-4 Targeting ADC (CRB-701)
|
